Ganymed Robotics, a leading developer of computer vision software and robotics technologies for orthopedic surgeons, has appointed five seasoned executives to its senior leadership team. These appointments are part of the company’s strategic plan to drive growth and prepare for industrialization and commercial launch.
The new executive committee consists of eight members, including Sophie Cahen as CEO and co-founder, Silvère Lucquin as Chief Operating Officer, and Michel Vernizeau as VP of R&D. The five new members bring expertise in product marketing, quality assurance and regulatory affairs, human resources, finance, and legal.
Ganymed Robotics aims to democratize access to quality care in hard tissue surgery and bring personalized care to each patient. The company’s first application is a co-manipulated surgical robotic assistant for total knee arthroplasty. Their proprietary technology platform is built around two disruptive innovations: contactless localization of the bones and human-machine collaborative movement.
Over the past 18 months, Ganymed Robotics has achieved significant milestones, including completing a 36 million euro Series B fundraising round, expanding its team, securing strategic partnerships, and winning innovation awards. With the addition of experienced senior executives, the company is well-positioned to accelerate its strategic, industrial, and operational development plan.
“I am delighted to partner with such talented senior executives who bring impressive experience and recognized expertise,” says Sophie Cahen, CEO of Ganymed Robotics. “Their arrival is a testament to our swift growth and shared purpose of revolutionizing orthopedic surgery.”
Ganymed Robotics was founded in 2018 and is based in Paris. The company combines computer vision and mechatronics to develop robotic assistance technologies for orthopedic surgery. They have received national and international innovation awards and plan to address various orthopedic indications in the future.
– Ganymed Robotics Press Release